Interstitial Lung Disease Within a Lung Cancer Screening

Interstitial lung disease is a devastating lung condition with terrible outcomes. Lung cancer is the world's leading cause of cancer related death. Unlike breast and bowel cancer, there is no lung cancer screening programme in the UK. However, there are a number of pilot lung cancer screening programmes taking place including one in Manchester. The CT scans used in lung cancer screening programmes pick up other lung conditions out with lung cancer, including interstitial lung disease. This provides a unique opportunity to diagnose interstitial lung disease at an early and non-symptomatic stage where treatment can be initiated early to halt progression of disease and development of symptoms. The investigators aim to determine how much (prevalence) interstitial lung disease can be picked up in a lung cancer screening programme and how these cases would compare to those diagnosed with interstitial lung disease through the 'standard' way in the clinics. The investigators hypothesis that the patients diagnosed through the screening programmes will have an earlier stage of disease with less symptoms. If this is to be the case, this would provide researchers with the opportunity to diagnose interstitial lung disease through lung cancer screening programmes and initiate treatment early.

Sex

All

Minimum age

50 Years

Maximum age

80 Years

Inclusion Criteria:

* Age 50-80
* Ever-smoker
* MDT diagnosis of ILD that has been detected through lung cancer screening or standard non-screening pathway
* Attended the regional ILD clinic

Exclusion Criteria:

* Unable to complete self-report questionnaire measures
* Unable to provide written informed consent